LMR Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-151,698
Closed -$7.05M 1098
2023
Q2
$7.05M Buy
+151,698
New +$5.24M 0.08% 220
2022
Q1
Sell
-15,387
Closed -$389K 1394
2021
Q4
$389K Sell
15,387
-44,613
-74% -$1.31M ﹤0.01% 970
2021
Q3
$1.97M Buy
+60,000
New +$2.04M 0.02% 460

LMR Partners's DICE Position: Q3 2023 in Review

LMR Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 151,698 shares — an estimated $7.05M sold.

LMR Partners first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $7.05M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • LMR Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • LMR Partners sold 151,698 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7.05M.
  • LMR Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • LMR Partners's DICE Therapeutics, Inc. Common Stock position peaked at $7.05M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.